Tata Multi Asset Allocation Fund Regular-Growth
The fund is rated 2.5 stars. The strongest area was balance between returns and downside risk, while investment selection within each industry provided some support. Asset mix did not provide enough support for a higher rating.
This fund has a bad track record with Asset Allocation, a ok track record with Stock Selection/Timing, a good risk-reward ratio. It is important to note, however, that this fund has a 5241.602 AUM and a 1.95 expense ratio. Considering all these factors, we have rated this fund as 2.5 star.
Our score weighs long-term performance, risk and consistency — not just past returns.
Returns
As of 6 Oct 2026
Risk ratios
As of 30 Sep 2026
Debt metrics
Portfolio
As of 31 Aug 2026
Market-cap split
Sector allocation
Holdings (101)
| Holding | % of fund | Value | Shares |
|---|---|---|---|
| Tata Gold ETF - Growth | 6.02% | ₹315.81 Cr | 21,11,00,000 |
| Reliance Industries Ltd. | 3.70% | ₹193.96 Cr | 15,18,852 |
| HDFC Bank Ltd. | 3.42% | ₹179.07 Cr | 25,25,728 |
| ICICI Bank Ltd. | 3.30% | ₹173.12 Cr | 11,90,675 |
| Bharti Airtel Ltd. | 2.56% | ₹134.18 Cr | 7,40,551 |
| Tata Silver ETF - Growth | 2.29% | ₹119.89 Cr | 5,30,00,000 |
| Axis Bank Ltd. | 1.75% | ₹91.65 Cr | 7,05,025 |
| State Bank of India | 1.63% | ₹85.57 Cr | 8,07,250 |
| Dr. Agarwal's Health Care Ltd. | 1.56% | ₹81.73 Cr | 15,92,474 |
| The Federal Bank Ltd. | 1.51% | ₹79.01 Cr | 22,15,132 |
Fund details
Long Term Capital Appreciation. Investment in equity & equity related instruments, debt instruments, exchange traded commodity derivatives and other instruments.
The scheme seeks to generate long term capital appreciation.
Exit load of 0.50%, if redeemed within 30 days.